Glenmark Pharmaceuticals Ltd

India's Glenmark to study potential Covid-19 drug combination
Coronavirus chronicle

India's Glenmark to study potential Covid-19 drug combination

The study will look to enroll 158 hospitalized patients of moderate Covid-19 in India

FILE PHOTO: Tablets of Avigan (generic name: Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato/File Photo
Coronavirus chronicle

Glenmark to conduct trials in India for potential Covid-19 drug